SNES - SenesTech, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
4.0500
-0.4800 (-10.60%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close4.5300
Open4.5000
Bid3.9100 x 1000
Ask4.2000 x 3100
Day's Range3.8600 - 4.5000
52 Week Range3.8500 - 39.0000
Volume79,527
Avg. Volume33,790
Market Cap5.587M
Beta (5Y Monthly)1.76
PE Ratio (TTM)N/A
EPS (TTM)-7.9330
Earnings DateNov 11, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est20.00
  • Zacks Small Cap Research

    SNES: SenesTech has announced preliminary unaudited revenue for the fourth quarter 2019 that were close to our estimates. It also outlined cost reductions including a reduction in headcount.

    By Ian Gilson, PhD, CFA NASDAQ:SNES READ THE FULL SNES RESEARCH REPORT SenesTech (NASDAQ:SNES) announced on Feb. 13 2020 that unaudited revenue for 4Q19 would by about $0.07 million as compared to our estimate of $0.08 million. A goal of a reduction in expenses of $1 million was also discussed. We assume that this includes the (previously announced) elimination of $0.137 million a quarter from

  • PR Newswire

    SenesTech Releases Preliminary Financials and Updates on Current Projects

    SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, announced today that preliminary unaudited revenues for the fourth quarter were approximately $70,000, compared to $36,000 in the third quarter of 2019, and approximately $149,000 for fiscal 2019, compared to $297,000 in 2018.

  • Zacks Small Cap Research

    SNES: SenesTech has announced a one for twenty reverse split effective February 04, 2020. We have adjusted our data to reflect the reverse split.

    By Ian Gilson, PhD, CFA NASDAQ:SNES READ THE FULL SNES RESEARCH REPORT On February 5, 2020, SenesTech (NASDAQ:SNES) stated to trade on a split adjusted basis. All shares will be converted into the new shares but fractional shares will be rounded UP to one whole share. We have adjusted our target price to $20 a share. The reverse split takes the share price above $5 so as long as the price remains

  • PR Newswire

    SenesTech Announces 1-for-20 Reverse Stock Split

    SenesTech, Inc. (NASDAQ: SNES), announced today that it will effect a 1-for-20 reverse stock split, previously approved by the Company's Board of Directors pursuant to the authority granted by the Company's stockholders at a special meeting held on January 31, 2020. The 1-for-20 reverse stock split will be effective as of 4:01 p.m. Eastern Time on February 4, 2020, and the Company's common stock will begin trading on a split-adjusted basis on Wednesday, February 5, 2020. The new CUSIP number for the Company's common stock following the reverse stock split is 81720R 208.

  • Did You Manage To Avoid SenesTech's (NASDAQ:SNES) 95% Share Price Wipe Out?
    Simply Wall St.

    Did You Manage To Avoid SenesTech's (NASDAQ:SNES) 95% Share Price Wipe Out?

    As every investor would know, not every swing hits the sweet spot. But you want to avoid the really big losses like...

  • PR Newswire

    SenesTech Announces Closing of $1.42 Million Registered Direct Offering

    SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, today announced the closing of its previously announced registered direct offering of 3,550,000 shares of its common stock, at a purchase price of $0.40 per share, for gross proceeds of $1.42 million. In a concurrent private placement, the Company also issued to the same investors unregistered warrants to purchase up to an aggregate of 3,550,000 shares of common stock at an exercise price of $0.45 per share. The unregistered warrants will be exercisable commencing six months following the date of issuance and will expire five and one-half years following the date of issuance.

  • Zacks Small Cap Research

    SNES: SenesTech to raise $1.42 million (gross) through a direct sale of stock. Estimates adjusted accordingly.

    By Ian Gilson, PhD, CFA NASDAQ:SNES READ THE FULL SNES RESEARCH REPORT SenesTech (NASDAQ:SNES) has announced that it will raise $1.42 million gross (about $1.28 net) from the sale of 3.55 million shares at $0.40 and the issuance of 3.55 million warrants at an exercise price of $0.45 that would not be registered at this time. The deal should close by the end of January 2020. We have adjusted our

  • PR Newswire

    SenesTech Announces $1.42 Million Registered Direct Offering

    SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, today announced that it has entered into definitive agreements with several institutional and accredited investors for the purchase and sale in a registered direct offering of 3,550,000 shares of SenesTech's common stock, at a purchase price of $0.40 per share, for gross proceeds of $1.42 million. SenesTech has also agreed to issue to the investors unregistered warrants to purchase up to an aggregate of 3,550,000 shares of common stock. The closing of the offering is expected to occur on or about January 28, 2020, subject to the satisfaction of customary closing conditions.

  • SNES: Store expansion continues online and globally
    Zacks Small Cap Research

    SNES: Store expansion continues online and globally

    NASDAQ:SNES To accelerate growth in the domestic market, SenesTech (NASDAQ:SNES) has launched an online store ( https://store.senestech.com ) since mid-December 2019. While ContraPest is also available through national and regional distributors, the online offering allows the brand to reach the U.S. consumers located throughout the country. (Source: Shutterstock) Products offered online include

  • Zacks Small Cap Research

    SNES: SenesTech launching a collaboration with Island Conservation to develop protocols for using ContraPest in environmentally sensitive areas.

    By Ian Gilson, PhD, CFA NASDAQ:SNES READ THE FULL SNES RESEARCH REPORT SenesTech (NASDAQ:SNES) has launched a collaborative effort with Island Conservation, a non-profit organization, to deploy ContraPest in environmentally sensitive areas to eliminate invasive species such as rats. The bait stations and the ContraPest will be sold by SenesTech, which will plan the treatment and support the

  • PR Newswire

    SenesTech Announces Joint Project with Island Conservation

    SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, announced today that it was launching a deployment project with Island Conservation. The project will specifically look at developing further protocols for deploying ContraPest® in environmentally sensitive areas, such as corporate campuses and conservation areas. Island Conservation and its corporate partners will purchase the ContraPest from SenesTech on standard terms, and SenesTech will contribute planning and deployment support.

  • Zacks Small Cap Research

    SNES: Expanding into SE Asia through a distribution agreement.

    By Ian Gilson, PhD, CFA NASDAQ:SNES READ THE FULL SNES RESEARCH REPORT The company has announced the signing of a distribution agreement with New Enterprises Ltd, an early investor in SenesTech (NASDAQ:SNES). New Enterprises will cover all costs of regulatory approval and market development as well as importation costs. This announcement is further confirmation of the potential of ContraPest in

  • PR Newswire

    SenesTech Announces Distribution Agreement for Maritime Southeast Asia

    SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, announced today that it had signed a distribution agreement with New Enterprises Ltd for the marketing and sales of ContraPest® in Singapore, Malaysia and Indonesia.

  • Zacks Small Cap Research

    SNES: Senestech expands marketing access with PMP centric web site.

    By Ian Gilson, PhD, CFA NASDAQ:SNES READ THE FULL SNES RESEARCH REPORT SenesTech (NASDAQ:SNES) has launched a new website aimed at pest management professionals (PMPs) that enables them to buy the company's products. These include bait stations, ContraPest control tanks and ContraPest tanks in both 400 mL and 550 mL sizes. Pricing per unit for ContraPest is $35 each (sold in lots of 8 tanks) for

  • PR Newswire

    SenesTech Announces Launch of Online Store to Order ContraPest Directly

    SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, today announced the launch of an online store to purchase ContraPest, the Company's revolutionary fertility control product for rodents.

  • SNES: Encouraging quarterly earnings results. Expect an uptick in sales in 2020.
    Zacks Small Cap Research

    SNES: Encouraging quarterly earnings results. Expect an uptick in sales in 2020.

    NASDAQ:SNES (Source: Shutterstock) Leptospira is a bacterium that is transmitted by rats to humans. As per CDC, contracting Leptospirosis can cause illness and when left untreated can lead to respiratory distress, kidney damage, liver failure and death. Some of the “rattiest” cities in the U.S. are New York, Washington D.C., Los Angeles, Chicago and San Francisco, to name a few. Rat infestations

  • Zacks Small Cap Research

    SNES: Results for the Washington DC project are very encouraging. ContraPest deployment in San Francisco and Los Angeles have been initiated. 2Q19 financials were close to our expectations.

    By Ian Gilson, PhD, CFA NASDAQ:SNES READ THE FULL SNES RESEARCH REPORT On Nov. 12, 2019, SenesTech (NASDAQ:SNES) reported its third quarter results. In general the numbers were in line with our estimates with revenue of $0.04 million (Est. $0.04 million) and, adjusted for non reoccurring professional and legal fees, the operating loss was $2.4 million (est. $2.1 million). The company is

  • PR Newswire

    SenesTech Announces Third Quarter 2019 Financial and Operational Results

    FLAGSTAFF, Ariz. , Nov. 12, 2019 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, today announced ...

  • PR Newswire

    SenesTech Announces Update on Washington DC ContraPest® Deployment

    FLAGSTAFF, Ariz., Nov. 12, 2019 /PRNewswire/ -- SenesTech, Inc. (SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, announced today positive progress on current deployment and site updates for fertility control in the city of Washington DC. "SenesTech agreed to provide a camera to DC Health in August 2019 to obtain information on how the rat populations in an alley in Adams Morgan was responding to ContraPest," said Brandy Pyzyna, Vice President of Scientific Operations.

  • PR Newswire

    SenesTech, Inc. to Report Third Quarter 2019 Financial Results on Tuesday, November 12, 2019

    FLAGSTAFF, Ariz., Nov. 5, 2019 /PRNewswire/ -- SenesTech, Inc. (SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, will report financial results for its third quarter of 2019, ended September 30, 2019, after the market close on Tuesday, November 12, 2019. The Company has scheduled a conference call that same day, Tuesday, November 12, 2019, at 5:00 pm ET, to review the results. Call-in Information: Interested parties can access the conference call by dialing (844) 308-3351 or (412) 317-5407.

  • Read This Before Selling SenesTech, Inc. (NASDAQ:SNES) Shares
    Simply Wall St.

    Read This Before Selling SenesTech, Inc. (NASDAQ:SNES) Shares

    We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. The...

  • SNES: A 21st century approach to curb rat infestation!
    Zacks Small Cap Research

    SNES: A 21st century approach to curb rat infestation!

    NASDAQ:SNES Background SenesTech Inc., head-quartered in Flagstaff, AZ was founded in 2004. The firm has developed a solution for managing pests through fertility control. Their current marketed product, ContraPest®, a liquid bait, limits fertility in male and female rats. ContraPest is the first and only non-lethal, fertility control product approved by the Environmental Protection Agency (EPA)

  • Zacks Small Cap Research

    SNES: Initiating coverage of SenesTech with a price target of $1.35

    By Ian Gilson, PhD, CFA NASDAQ:SNES READ THE FULL SNES RESEARCH REPORT SenesTech Inc. (NASDAQ:SNES) is in the transition from being a drug discovery company to commercialization of its rodenticide contraceptive, ContraPest. The replacement of second generation anti-coagulant products with alternative treatments would open a multimillion dollar market in the

  • PR Newswire

    SenesTech Expands ContraPest® in Organic Agriculture

    "The organic industry is a natural part of our broader food and agriculture strategy," said Kenneth Siegel, SenesTech's CEO. "As with their conventional counterparts, organic facilities have struggled with rodent management and are looking for effective solutions.  ContraPest, either alone or as part of a broader integrated pest management program, offers them a new alternative that will reduce both product loss and contamination risk.

  • PR Newswire

    ContraPest® Sales Expand in California Agriculture

    FLAGSTAFF, Ariz., Sept. 16, 2019 /PRNewswire/ -- SenesTech, Inc. (SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, announced today regulatory approval for expanded use of ContraPest® in agricultural settings in California, and expanded sales to agricultural customers. The California Certified Organic Farmers (CCOF) has provided approval for ContraPest use at Lundberg Farms, one of the largest organic rice farming operations in the state.